FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2062497 · Received April 19, 2011

Report

Report Number
2124215-2011-06837
Event Type
Malfunction
Date Received
April 19, 2011
Date of Event
March 22, 2011
Report Date
April 20, 2016
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS ISSUE WILL BE RE-EVALUATED IF ADDITIONAL INFORMATION IS RECEIVED.

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION WAS RECEIVED THIRTEEN MONTHS LATER STATING THAT THE RED ALERTS ARE STILL BEING PRODUCED DUE TO HIGH SHOCK IMPEDANCE MEASUREMENTS. THE INFORMATION HAS BEEN COMMUNICATED TO THIS PATIENT'S PHYSICIAN. THIS PRODUCT ISSUE WILL BE UPDATED IF ADDITIONAL INFORMATION IS RECEIVED.

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION WAS RECEIVED TWENTY ONE MONTHS FOLLOWING THE INITIAL CLINICAL OBSERVATIONS STATING THAT THE RED ALERTS ARE STILL BEING PRODUCED DUE TO HIGH SHOCK IMPEDANCE MEASUREMENTS. THE INFORMATION HAS BEEN COMMUNICATED TO THIS PATIENT'S PHYSICIAN. THIS PRODUCT ISSUE WILL BE UPDATED IF ADDITIONAL INFORMATION IS RECEIVED.

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION WAS RECEIVED STATING THAT THE RED ALERTS ARE STILL BEING PRODUCED DUE TO HIGH SHOCK IMPEDANCE MEASUREMENTS. A REVIEW OF THE DATA SHOWED THE MEASUREMENTS HAVE RANGED FROM 80 OHMS TO 138 OHMS OVER THE PAST YEAR. THE BOSTON SCIENTIFIC SALES REPRESENTATIVE STATED THAT NO TESTING WAS PERFORMED TO IDENTIFY THE CAUSE OF THE OUT OF RANGE MEASUREMENTS AND THE PATIENT WILL CONTINUE TO BE FOLLOWED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT A RED ALERT WAS RECEIVED STATING A HIGH SHOCK IMPEDANCE MEASUREMENT HAD BEEN DETECTED WITH THIS SYSTEM. THE PATIENT WAS GOING TO BE SEEN FOR AN EVALUATION; HOWEVER, HE DID NOT SHOW UP FOR THE FOLLOW UP VISIT. NO OTHER ADVERSE EVENTS HAVE BEEN REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWP GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 60 YR E110| 4469